EBMT−NIH−CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment

• DOI: 10.1038/s41409-018-0204-7
• Publication Date: 2018-06-05T09:06:39Z
• Authors: Helene M. Schoemans; Stephanie J. Lee; James L. Ferrara; Daniel Wolff; John E. Levine; Kirk R. Schultz; Bronwen E. Shaw; Mary E. Flowers; Tapani Ruutu; Hildegard Greinix; Ernst Holler; Grzegorz Basak; Rafael F. Duarte; Steven Z. Pavletic
• Keywords: Statement (logic); Position statement; Task force

Several international recommendations address the assessment of graft-versus-host disease (GvHD) after hematopoietic cell transplantation (HCT). This position statement by GvHD experts from European Society for Blood and Marrow Transplantation (EBMT), National Institutes Health (NIH) Center International Transplant Research (CIBMTR) reviews existing guidelines both acute chronic GvHD, addresses potential confusions that arise in daily practice proposes consensus definitions many key terms. We provide a historical perspective on currently available recommend Mount Sinai Acute Consortium (MAGIC) criteria NIH 2014 as most comprehensive detailed available. also offers practical guidance implementation these set commonly used terms order to facilitate future clinical translational research. To assist dissemination recommendations, web-application based this is ( https://www.uzleuven.be/egvhd ). believe adherence common vitally important improve quality data, compare results retrospective studies prospective trials, make therapeutic evidence.